Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction

Masafumi Takeda, Tomoya Yamashita, Masakazu Shinohara, Naoto Sasaki, Tomofumi Takaya, Kenji Nakajima, Nobutaka Inoue, Tomoya Masano, Hideto Tawa, Seimi Satomi-Kobayashi, Ryuji Toh, Daisuke Sugiyama, Kunihiro Nishimura, Mitsuhiro Yokoyama, Ken Ichi Hirata, Seinosuke Kawashima

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Although endothelium-dependent vasodilatation has been used as a marker of endothelial dysfunction (ED), there have been no reliable plasma markers for ED. Oxidative stress, which is a major determinant of ED, oxidizes tetrahydrobiopterin (BH4), an essential cofactor of endothelial type nitric oxide synthase (eNOS), and resulted in the relative deficiency of BH4. Methods and Results: In 163 patients with cardiovascular disorders, the plasma levels of BH4 and 7, 8-dihydrobiopterin (BH2) by high performance liquid chromatography were measured and compared with the flow-mediated (FMD) vasodilatory response of the brachial artery, which was measured by ultrasonography. The effects of atorvastatin on plasma pteridine levels and FMD were examined in patients with multiple coronary risk factors. There was a positive relationship between FMD and plasma BH4 levels and a negative relationship between FMD and plasma BH2 levels. Subsequently, a strong positive relationship between FMD and the BH4/BH2 ratio (r=0.585, P<0.0001) was found. Although we did not find any significant relationship between pteridine levels and individual traditional risk factors, the BH4/BH2 ratio in patients with more than 2 risk factors showed significant reductions compared with that in those without risk factors. Statin treatment improved FMD in association with an increase in the plasma BH4/BH2 ratio. Conclusions: Plasma pteridine levels were associated with endothelial dysfunction in cardiovascular disorders.

Original languageEnglish
Pages (from-to)955-962
Number of pages8
JournalCirculation Journal
Volume73
Issue number5
DOIs
Publication statusPublished - 2009 May
Externally publishedYes

Fingerprint

Pteridines
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Phenylketonurias
Brachial Artery
Nitric Oxide Synthase Type III
7,8-dihydrobiopterin
sapropterin
Vasodilation
Endothelium
Ultrasonography
Oxidative Stress
High Pressure Liquid Chromatography
Therapeutics

Keywords

  • Endothelial dysfunction
  • FMD
  • Plasma pteridine level
  • Statin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Takeda, M., Yamashita, T., Shinohara, M., Sasaki, N., Takaya, T., Nakajima, K., ... Kawashima, S. (2009). Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction. Circulation Journal, 73(5), 955-962. https://doi.org/10.1253/circj.CJ-08-0850

Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction. / Takeda, Masafumi; Yamashita, Tomoya; Shinohara, Masakazu; Sasaki, Naoto; Takaya, Tomofumi; Nakajima, Kenji; Inoue, Nobutaka; Masano, Tomoya; Tawa, Hideto; Satomi-Kobayashi, Seimi; Toh, Ryuji; Sugiyama, Daisuke; Nishimura, Kunihiro; Yokoyama, Mitsuhiro; Hirata, Ken Ichi; Kawashima, Seinosuke.

In: Circulation Journal, Vol. 73, No. 5, 05.2009, p. 955-962.

Research output: Contribution to journalArticle

Takeda, M, Yamashita, T, Shinohara, M, Sasaki, N, Takaya, T, Nakajima, K, Inoue, N, Masano, T, Tawa, H, Satomi-Kobayashi, S, Toh, R, Sugiyama, D, Nishimura, K, Yokoyama, M, Hirata, KI & Kawashima, S 2009, 'Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction', Circulation Journal, vol. 73, no. 5, pp. 955-962. https://doi.org/10.1253/circj.CJ-08-0850
Takeda, Masafumi ; Yamashita, Tomoya ; Shinohara, Masakazu ; Sasaki, Naoto ; Takaya, Tomofumi ; Nakajima, Kenji ; Inoue, Nobutaka ; Masano, Tomoya ; Tawa, Hideto ; Satomi-Kobayashi, Seimi ; Toh, Ryuji ; Sugiyama, Daisuke ; Nishimura, Kunihiro ; Yokoyama, Mitsuhiro ; Hirata, Ken Ichi ; Kawashima, Seinosuke. / Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction. In: Circulation Journal. 2009 ; Vol. 73, No. 5. pp. 955-962.
@article{ee28a114d1e24cf6b6ff6be8168e9e8c,
title = "Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction",
abstract = "Background: Although endothelium-dependent vasodilatation has been used as a marker of endothelial dysfunction (ED), there have been no reliable plasma markers for ED. Oxidative stress, which is a major determinant of ED, oxidizes tetrahydrobiopterin (BH4), an essential cofactor of endothelial type nitric oxide synthase (eNOS), and resulted in the relative deficiency of BH4. Methods and Results: In 163 patients with cardiovascular disorders, the plasma levels of BH4 and 7, 8-dihydrobiopterin (BH2) by high performance liquid chromatography were measured and compared with the flow-mediated (FMD) vasodilatory response of the brachial artery, which was measured by ultrasonography. The effects of atorvastatin on plasma pteridine levels and FMD were examined in patients with multiple coronary risk factors. There was a positive relationship between FMD and plasma BH4 levels and a negative relationship between FMD and plasma BH2 levels. Subsequently, a strong positive relationship between FMD and the BH4/BH2 ratio (r=0.585, P<0.0001) was found. Although we did not find any significant relationship between pteridine levels and individual traditional risk factors, the BH4/BH2 ratio in patients with more than 2 risk factors showed significant reductions compared with that in those without risk factors. Statin treatment improved FMD in association with an increase in the plasma BH4/BH2 ratio. Conclusions: Plasma pteridine levels were associated with endothelial dysfunction in cardiovascular disorders.",
keywords = "Endothelial dysfunction, FMD, Plasma pteridine level, Statin",
author = "Masafumi Takeda and Tomoya Yamashita and Masakazu Shinohara and Naoto Sasaki and Tomofumi Takaya and Kenji Nakajima and Nobutaka Inoue and Tomoya Masano and Hideto Tawa and Seimi Satomi-Kobayashi and Ryuji Toh and Daisuke Sugiyama and Kunihiro Nishimura and Mitsuhiro Yokoyama and Hirata, {Ken Ichi} and Seinosuke Kawashima",
year = "2009",
month = "5",
doi = "10.1253/circj.CJ-08-0850",
language = "English",
volume = "73",
pages = "955--962",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "5",

}

TY - JOUR

T1 - Plasma tetrahydrobiopterin/dihydrobiopterin ratio - A possible marker of endothelial dysfunction

AU - Takeda, Masafumi

AU - Yamashita, Tomoya

AU - Shinohara, Masakazu

AU - Sasaki, Naoto

AU - Takaya, Tomofumi

AU - Nakajima, Kenji

AU - Inoue, Nobutaka

AU - Masano, Tomoya

AU - Tawa, Hideto

AU - Satomi-Kobayashi, Seimi

AU - Toh, Ryuji

AU - Sugiyama, Daisuke

AU - Nishimura, Kunihiro

AU - Yokoyama, Mitsuhiro

AU - Hirata, Ken Ichi

AU - Kawashima, Seinosuke

PY - 2009/5

Y1 - 2009/5

N2 - Background: Although endothelium-dependent vasodilatation has been used as a marker of endothelial dysfunction (ED), there have been no reliable plasma markers for ED. Oxidative stress, which is a major determinant of ED, oxidizes tetrahydrobiopterin (BH4), an essential cofactor of endothelial type nitric oxide synthase (eNOS), and resulted in the relative deficiency of BH4. Methods and Results: In 163 patients with cardiovascular disorders, the plasma levels of BH4 and 7, 8-dihydrobiopterin (BH2) by high performance liquid chromatography were measured and compared with the flow-mediated (FMD) vasodilatory response of the brachial artery, which was measured by ultrasonography. The effects of atorvastatin on plasma pteridine levels and FMD were examined in patients with multiple coronary risk factors. There was a positive relationship between FMD and plasma BH4 levels and a negative relationship between FMD and plasma BH2 levels. Subsequently, a strong positive relationship between FMD and the BH4/BH2 ratio (r=0.585, P<0.0001) was found. Although we did not find any significant relationship between pteridine levels and individual traditional risk factors, the BH4/BH2 ratio in patients with more than 2 risk factors showed significant reductions compared with that in those without risk factors. Statin treatment improved FMD in association with an increase in the plasma BH4/BH2 ratio. Conclusions: Plasma pteridine levels were associated with endothelial dysfunction in cardiovascular disorders.

AB - Background: Although endothelium-dependent vasodilatation has been used as a marker of endothelial dysfunction (ED), there have been no reliable plasma markers for ED. Oxidative stress, which is a major determinant of ED, oxidizes tetrahydrobiopterin (BH4), an essential cofactor of endothelial type nitric oxide synthase (eNOS), and resulted in the relative deficiency of BH4. Methods and Results: In 163 patients with cardiovascular disorders, the plasma levels of BH4 and 7, 8-dihydrobiopterin (BH2) by high performance liquid chromatography were measured and compared with the flow-mediated (FMD) vasodilatory response of the brachial artery, which was measured by ultrasonography. The effects of atorvastatin on plasma pteridine levels and FMD were examined in patients with multiple coronary risk factors. There was a positive relationship between FMD and plasma BH4 levels and a negative relationship between FMD and plasma BH2 levels. Subsequently, a strong positive relationship between FMD and the BH4/BH2 ratio (r=0.585, P<0.0001) was found. Although we did not find any significant relationship between pteridine levels and individual traditional risk factors, the BH4/BH2 ratio in patients with more than 2 risk factors showed significant reductions compared with that in those without risk factors. Statin treatment improved FMD in association with an increase in the plasma BH4/BH2 ratio. Conclusions: Plasma pteridine levels were associated with endothelial dysfunction in cardiovascular disorders.

KW - Endothelial dysfunction

KW - FMD

KW - Plasma pteridine level

KW - Statin

UR - http://www.scopus.com/inward/record.url?scp=65649104427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649104427&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-08-0850

DO - 10.1253/circj.CJ-08-0850

M3 - Article

VL - 73

SP - 955

EP - 962

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 5

ER -